270 related articles for article (PubMed ID: 19596788)
41. Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins.
Charbonneau A; Marette A
Diabetes; 2010 Apr; 59(4):861-71. PubMed ID: 20103705
[TBL] [Abstract][Full Text] [Related]
42. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling.
Shi H; Tzameli I; Bjørbaek C; Flier JS
J Biol Chem; 2004 Aug; 279(33):34733-40. PubMed ID: 15181014
[TBL] [Abstract][Full Text] [Related]
43. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
Enooku K; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Tsutsumi T; Nakagomi R; Minami T; Sato M; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Fukayama M; Koike K
J Gastroenterol; 2018 Dec; 53(12):1261-1275. PubMed ID: 29749571
[TBL] [Abstract][Full Text] [Related]
44. Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.
Forand A; Koumakis E; Rousseau A; Sassier Y; Journe C; Merlin JF; Leroy C; Boitez V; Codogno P; Friedlander G; Cohen I
Cell Rep; 2016 Sep; 16(10):2736-2748. PubMed ID: 27568561
[TBL] [Abstract][Full Text] [Related]
45. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice.
Sun Y; Liu S; Ferguson S; Wang L; Klepcyk P; Yun JS; Friedman JE
J Biol Chem; 2002 Jun; 277(26):23301-7. PubMed ID: 11964395
[TBL] [Abstract][Full Text] [Related]
46. Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and glutamine or glucose deprivation.
Minchenko DO; Kharkova AP; Hubenia OV; Minchenko OH
Endocr Regul; 2013 Jan; 47(1):15-26. PubMed ID: 23363253
[TBL] [Abstract][Full Text] [Related]
47. Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.
Porter HA; Carey GB; Keegan AD
Exp Cell Res; 2012 Aug; 318(14):1745-58. PubMed ID: 22652453
[TBL] [Abstract][Full Text] [Related]
48. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
49. FoxO1 links hepatic insulin action to endoplasmic reticulum stress.
Kamagate A; Kim DH; Zhang T; Slusher S; Gramignoli R; Strom SC; Bertera S; Ringquist S; Dong HH
Endocrinology; 2010 Aug; 151(8):3521-35. PubMed ID: 20501674
[TBL] [Abstract][Full Text] [Related]
50. [Effects of Electroacupuncture on mRNA Expressions of Insulin-receptor Substrates 1 and 2 in the Endometrium of PCOS Rats and Insulin Sensitivity].
Lai MH; Ma HX; Li J; Song XH; Liu H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1082-1086. PubMed ID: 30645847
[TBL] [Abstract][Full Text] [Related]
51. Dioscin attenuates high‑fat diet‑induced insulin resistance of adipose tissue through the IRS‑1/PI3K/Akt signaling pathway.
Li H; Yu L; Zhao C
Mol Med Rep; 2019 Feb; 19(2):1230-1237. PubMed ID: 30483735
[TBL] [Abstract][Full Text] [Related]
52. Insulin receptor substrate 2 and FoxO3a signalling are involved in E-cadherin expression and transforming growth factor-β1-induced repression in kidney epithelial cells.
Carew RM; Browne MB; Hickey FB; Brazil DP
FEBS J; 2011 Sep; 278(18):3370-80. PubMed ID: 21777391
[TBL] [Abstract][Full Text] [Related]
53. Differential insulin receptor substrate-1 (IRS1)-related modulation of neuropeptide Y and proopiomelanocortin expression in nondiabetic and diabetic IRS2-/- mice.
Burgos-Ramos E; González-Rodríguez A; Canelles S; Baquedano E; Frago LM; Revuelta-Cervantes J; Gómez-Ambrosi J; Frühbeck G; Chowen JA; Argente J; Valverde AM; Barrios V
Endocrinology; 2012 Mar; 153(3):1129-40. PubMed ID: 22210743
[TBL] [Abstract][Full Text] [Related]
54. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
55. Insulin receptor substrate 2 is required for testicular development.
Griffeth RJ; Carretero J; Burks DJ
PLoS One; 2013; 8(5):e62103. PubMed ID: 23741292
[TBL] [Abstract][Full Text] [Related]
56. Muscle-specific knock-out of NUAK family SNF1-like kinase 1 (NUAK1) prevents high fat diet-induced glucose intolerance.
Inazuka F; Sugiyama N; Tomita M; Abe T; Shioi G; Esumi H
J Biol Chem; 2012 May; 287(20):16379-89. PubMed ID: 22418434
[TBL] [Abstract][Full Text] [Related]
57. Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption.
Zheng Y; Yamada H; Sakamoto K; Horita S; Kunimi M; Endo Y; Li Y; Tobe K; Terauchi Y; Kadowaki T; Seki G; Fujita T
J Am Soc Nephrol; 2005 Aug; 16(8):2288-95. PubMed ID: 15975995
[TBL] [Abstract][Full Text] [Related]
58. The pseudophosphatase phogrin enables glucose-stimulated insulin signaling in pancreatic β cells.
Torii S; Kubota C; Saito N; Kawano A; Hou N; Kobayashi M; Torii R; Hosaka M; Kitamura T; Takeuchi T; Gomi H
J Biol Chem; 2018 Apr; 293(16):5920-5933. PubMed ID: 29483197
[TBL] [Abstract][Full Text] [Related]
59. Chlorpromazine exacerbates hepatic insulin sensitivity via attenuating insulin and leptin signaling pathway, while exercise partially reverses the adverse effects.
Park S; Hong SM; Lee JE; Sung SR
Life Sci; 2007 Jun; 80(26):2428-35. PubMed ID: 17512020
[TBL] [Abstract][Full Text] [Related]
60. WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.
Zhang L; Li X; Zhang N; Yang X; Hou T; Fu W; Yuan F; Wang L; Wen H; Tian Y; Zhang H; Lu X; Zhu WG
Diabetes; 2020 Sep; 69(9):1887-1902. PubMed ID: 32641353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
